Press briefing on EU recommendation for COVID-19 Vaccine AstraZeneca

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

Date

piątek, 29 Styczeń 2021, Cały dzień

Miejsce

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

This virtual press briefing will discuss the outcome of the evaluation of COVID-19 Vaccine AstraZeneca by EMA’s human medicines committee (CHMP).

Speakers include:

  • Emer Cooke (EMA's Executive Director)
  • Bruno Sepodes (CHMP Vice-chair)
  • Sabine Straus (PRAC Chair)
  • Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy).

Marie-Agnes Heine, EMA's Head of Communication, will moderate the press briefing.

The press briefing is held in English. 

Video recording

Share this page